The identification of EFHD1, SASH1, FAM110B, and SLC25A18 as significant cross-disease markers sheds light on the shared and divergent mitochondrial mechanisms at play in AD and GBM. The gene discussed is SLC25A18; the disease is Alzheimer disease.